Trump administration nominates Heidi Overton as FDA commissioner after acting chief declines
read at STAT ↗RegulatoryNeutral
The White House announced that Heidi Overton has been nominated to lead the Food and Drug Administration after acting commissioner Kyle Diamantas turned down a permanent appointment.
Reports from Daniel Payne and Chelsea Cirruzzo indicate the choice reflects the administration's preference for a loyalist with close ties to the former president.
The nomination arrives as the administration seeks to influence health‑policy direction, drawing interest from pharmaceutical companies and regulators alike.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: How a Trump loyalist got the FDA nomination”
read at STAT ↗420 words · retrieved Aug 20
comments(0)
5-min edit window · permanent after that